REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $159,160 | +17.1% | 1,561 | +4.4% | 0.01% | +14.3% |
| Q1 2023 | $135,925 | +100.4% | 1,495 | -16.2% | 0.01% | +133.3% |
| Q4 2022 | $67,812 | +51.2% | 1,785 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $44,857 | -17.3% | 1,785 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $54,246 | -7.2% | 1,785 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $58,477 | -70.6% | 1,785 | -76.3% | 0.00% | -33.3% |
| Q4 2021 | $198,803 | -73.8% | 7,539 | 0.0% | 0.00% | -72.7% |
| Q3 2021 | $758,499 | -28.8% | 7,539 | +0.1% | 0.01% | -26.7% |
| Q2 2021 | $1,065,862 | +508.8% | 7,531 | +328.9% | 0.02% | +400.0% |
| Q1 2021 | $175,073 | -15.8% | 1,756 | +4.4% | 0.00% | 0.0% |
| Q4 2020 | $207,929 | +24.5% | 1,682 | -1.9% | 0.00% | 0.0% |
| Q3 2020 | $167,075 | -38.3% | 1,715 | -1.2% | 0.00% | -40.0% |
| Q2 2020 | $270,851 | -72.7% | 1,736 | -74.8% | 0.01% | -76.2% |
| Q1 2020 | $993,059 | -28.6% | 6,880 | +1.1% | 0.02% | -8.7% |
| Q4 2019 | $1,391,759 | +162.7% | 6,808 | +3.2% | 0.02% | +155.6% |
| Q3 2019 | $529,834 | -9.1% | 6,599 | +6.8% | 0.01% | -10.0% |
| Q2 2019 | $583,083 | +12.4% | 6,180 | +1.8% | 0.01% | +11.1% |
| Q1 2019 | $518,888 | +52.4% | 6,071 | 0.0% | 0.01% | +28.6% |
| Q4 2018 | $340,583 | -31.4% | 6,071 | 0.0% | 0.01% | -22.2% |
| Q3 2018 | $496,365 | -99.7% | 6,071 | +11.2% | 0.01% | +200.0% |
| Q2 2018 | $190,936,000 | +161.3% | 5,460 | +53.2% | 0.00% | +200.0% |
| Q1 2018 | $73,077,000 | +72253.5% | 3,563 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $101,000 | -50.0% | 3,563 | -45.1% | 0.00% | 0.0% |
| Q3 2017 | $202,000 | -1.5% | 6,492 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $205,000 | – | 6,492 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |